Electronic Health Records for dementia care research in 2026 are digital clinic notes and test results that scientists study to spot risk earlier. Adult children can ask how records are used, whether they are identified, and who may consent for a parent.
An electronic health record, or EHR, is the longitudinal file your parent's clinic keeps. Researchers now mine those files to map decline and flag high-risk patients for follow-up. Clear questions help families weigh benefit, burden, and privacy.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How are records helping doctors spot risk earlier?
- Why do large record studies matter for daily care?
- Will a study use identified or de-identified records?
- What should adult children ask before joining?
How are records helping doctors spot risk earlier?
UMass Lowell researchers led by Hong Yu used machine learning on veterans' clinical notes and 122 keywords to flag Alzheimer's risk up to 15 years earlier than current standards, according to UMass Lowell in the university's research announcement. The work focused on language already in routine notes. It points to earlier watchfulness, not a diagnosis by itself.
EHR-based screening also helped primary-care clinicians identify patients at high risk for mild cognitive impairment and dementia for targeted follow-up in the eRADAR pragmatic trials presented at AAIC 2026 in London, as reported by Healio in Healio's AAIC 2026 coverage. That means a flag can trigger memory checks, labs, or referral. Families can ask what follow-up a flag would trigger.
Why do large record studies matter for daily care?
The M3AD Study harmonized records for nearly 10 million patients, including about 60,000 with Alzheimer's or related dementias across three U.S. cities plus census-tract context, to track disease paths for precision-aging work, according to MedicalXpress reporting on the 2026 study in Alzheimer's and Dementia in MedicalXpress's study report. Neighborhood context helps explain different trajectories.
It may guide more personal timing of support and services. University of Florida scientists also used artificial intelligence on deidentified 2012-2024 UF Health records and found glucosamine use linked with 25% higher progression from mild cognitive impairment to dementia. The authors called the result preliminary and needing human-trial validation. Do not stop a supplement on this finding alone; bring the list to the visit.
Will a study use identified or de-identified records?
Identifiable data generally needs patient authorization or a board waiver limited to the minimum necessary. Properly de-identified data can be used for research without authorization, so the distinction matters for privacy. The University of Missouri-Kansas City explains this HIPAA Basics rule for research use.
Ask whether your parent's name, dates, or contact details stay attached. Ask who sees identified files, how long they are kept, and whether data are shared outside the health system. Ask if de-identification happens before analysis and whether future studies may reuse the same file.
What should adult children ask before joining?
The Alzheimer's Association, citing the National Institute on Aging, advises asking about purpose, tests and treatments, risks and side effects, duration and visits, possible benefits, costs and insurance, privacy protections, and how results and next steps are shared. Use that list to run the conversation. Take notes and request written answers.
Banner Health notes that dementia studies add an assent process allowing a caregiver or other legally authorized representative to enroll a person with Alzheimer's alongside informed consent. So ask who may consent, whether a study partner is required, and what happens if your parent dissents on the day. Bring guardianship papers, a medication list, and one main contact for follow-up calls.
- Why is my parent a match, and what will each visit require?
- What are risks, side effects, costs, and time demands for the study partner?
- How is privacy protected, and how will we learn results?
You Might Also Like
- Serious Illness and End-of-Life Dementia Research Priorities in 2026: Questions Adult Children Can Ask Local Care Programs
- The Long-Term Care Data Cooperative and Dementia Research in 2026: Study Design and Evidence Limits for Adult Children
- Pregnancy Complications With a Family History of Alzheimer’s: Questions to Ask About Brain Health
